Record Q4 and year-end total revenues of $23.4 million and $82.2 million, representing a 28% and 43% increase compared to the same periods in 2023.Robust growth in Q4 over Q3 2024, with total...
MONTREAL, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis...
Gross cannabis revenues before excise taxes increased to $26.2 million in Q3 2024 from $20.6 million in Q3 2023, a $5.6 million or 27.6%, increase. Total revenues, net of excise taxes, increased...
Cannara Biotech Inc. Enters into Definitive Agreement to Acquire TGOD's State-of-the-Art Cultivation and Manufacturing Facility in Valleyfield, Quebec Newly built fully automated one...
Cannara Biotech Delivers Strong Q2 2021 Results Significant second quarter revenue generation of $1.2 million and gross profit increase to $2.1 million showcases Cannara's...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.07 | 10.2941176471 | 0.68 | 0.78 | 0.68 | 14415 | 0.76411 | CS |
4 | -0.04 | -5.06329113924 | 0.79 | 0.79 | 0.58 | 17349 | 0.68248781 | CS |
12 | 0.1 | 15.3846153846 | 0.65 | 0.8 | 0.57 | 15962 | 0.67972852 | CS |
26 | 0.01 | 1.35135135135 | 0.74 | 0.8 | 0.52 | 20097 | 0.66722108 | CS |
52 | -0.11 | -12.7906976744 | 0.86 | 1.04 | 0.52 | 21759 | 0.77444585 | CS |
156 | 0.625 | 500 | 0.125 | 1.15 | 0.085 | 69182 | 0.22515701 | CS |
260 | 0.59 | 368.75 | 0.16 | 1.15 | 0.085 | 129834 | 0.18706763 | CS |
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관